KIN and melanoma: The kin17 protein has been described as a potential diagnostic biomarker for breast cancer [4], which suggests that an analysis in human melanoma tissues is important to determine whether the level of kin17 could also be used as a biomarker for the identification of tumors with low and/or high metastatic capacity.